LAMONIA PARKER: Open Payments
NPI 1851892004 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 22 payments from 13 companies in 2025. Trend: 2023 $201 · 2024 $49 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 4 | $70 |
| Sage Therapeutics, LLC | 3 | $69 |
| MILLICENT US INC | 3 | $66 |
| Astellas Pharma US Inc | 2 | $47 |
| Smith+Nephew, Inc. | 1 | $37 |
| CooperSurgical, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Organon LLC | 1 | $20 |
Products named: ACCRUFER, ZURZUVAE, Veozah, PICO 7, Paragard T 380A, Mirena, FEMLYV, INTRAROSA.
Industry payments across TX — which companies pay providers there.
